NEW Lunit logo(white_on)

Meet Lunit at EUSOBI 2025

📅 September 25-27, 2025
🌍 P&J Live, Aberdeen, UK
📌 Booth M9

From image acquisition to cancer detection, our AI-driven solutions support every step of the breast screening workflow

Our presence at EUSOBI 2025

🎙️ Attend the Lunit Symposium: Updates on the Leeds prospective trial - Implementing AI in the symptomatic breast pathway

Nisha pic

  • Speaker: Dr. Nisha Sharma

  • Date & Time: Friday, Sept 26 | 12:20-12:35 (AI Focus Session)

  • Location: 1F, Conference Room 1B

Symptomatic breast clinics face growing demand and workforce shortages. Dr. Nisha Sharma will share two-year progress from the world’s first prospective trial evaluating Lunit INSIGHT MMG in symptomatic pathways, including trial findings and real-world feedback from radiologists and patients.

→ Read more about the Leeds trial

👩‍⚕️ Meet our team at the Lunit booth (#M9)

Join us at the Lunit booth in the EUSOBI exhibition hall to connect with our experts and: 

  • See live demos of our AI solutions
  • Discuss implementation strategies tailored to your screening program or clinical workflow
  • Explore research collaboration opportunities and learn about our latest clinical evidence.
  • Meet the team driving the Lunit AI adoption across Europe.
👉 Schedule a 1:1 meeting with us directly onsite.
EUSOBI 2025 floorplan

Program Highlight: Implementation of AI as the second reader in a double screening workflow

Karin Dembrower

  • Session: AI – from Gadget to Gain (Session 4

  • Presentation: Implementation of Clinical Artificial Intelligence in Breast Radiology: Who Decides and How?

  • Speaker: Dr. Karin Dembrower

  • Date & Time: Friday, Sept 26 | 09:00-09:15

  • Location: Main conference hall

St. Göran Hospital in Stockholm became the first site in Europe to adopt AI as the second reader in a double screening workflow. At EUSOBI, Dr. Dembrower will share the latest clinical impact measured and discuss how AI is integrated into breast radiology practice.

Discover our AI-powered solutions for Breast Cancer Detection

Over one year since joining forces, Lunit and Volpara are delivering AI-driven solutions that strengthen every step of the breast screening journey. From early detection to improved workflow efficiency, our combined expertise is helping radiologists, radiographers, and healthcare systems achieve better outcomes for patients.

RSNA 2024_landing page_MMG

Lunit INSIGHT Breast Suite

Find cancers unseen to the human eye: Lesion detection on 2D/3D mammography.

Learn more
Analytics-monitor

Volpara Analytics™

Improve image quality for more accurate diagnoses. Streamline workflows and compliance management.

Learn more
Scorecard-monitor-1

Volpara Scorecard™

Measure breast density automatically, objectively and volumetrically for more precise risk assessment

Learn more

📃 Clinical evidence: AI with proven impact

With 400+ peer-reviewed publications, Lunit brings one of the strongest evidence bases in breast imaging AI. Recent highlights include:

  • Enhanced performance in real-world settings: ​

    • Swedish ScreenTrustCAD: AI achieved higher PPV for recalls, even though a larger proportion of recalls were made by humans (Dembrower et al., Radiology 2025)​

    • Prospective trial evidence (AI-STREAM) confirms meaningful gains in cancer detection rate regardless of radiologists experience level, without added recalls (Chang et al., Nature Communication 2025)​

  • Accuracy & localization: AI and humans both correctly detect 88% of cancers, but AI outperform humans in correctly localising the lesions (Gani et al., European Radiology 2025) - UK evidence​

  • Complementarity detection: AI and humans detect different cancers – AI sees what humans may miss, and vice versa – demonstrating complementary strengths (van Winkel et al., Diagnostics 2025)​

  • Contralateral surveillance post-mastectomy: AI performs with high sensitivity (Ha et al., Radiology 2025)​

🌍 Real-world adoption of our solutions in Europe

Lunit INSIGHT Breast Suite is being adopted at scale throughout Europe's public sector. A few of our most recent achievements include:
Screenshot 2025-09-11 172612
Screenshot 2025-09-11 172623
Screenshot 2025-09-11 172632

Let's connect at EUSOBI 2025

Interested in learning more about our research, solutions, or partnership opportunities? Secure your meeting with our team.

A question? Send us a message and we will get back to you as soon as possible.

We are looking forward to meeting you at EUSOBI 2025!